<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="openVirus\examples\priya950\4-part\PMC7270913\results\search\disease\results.xml">
  <result pre="Press pmcid: 7270913 doi: 10.1093/eurheartj/suaa064suaa064 : Articles Causal relationship between" exact="influenza" post="infection and risk of acute myocardial infarction: pathophysiological hypothesis"/>
  <result pre="journals.permissions@oup.comsuaa064.pdf Abstract Abstract Presently several evidences support an association between" exact="acute myocardial infarction" post="and influenza infection. The pathophysiology rationale rests on the"/>
  <result pre="several evidences support an association between acute myocardial infarction and" exact="influenza" post="infection. The pathophysiology rationale rests on the release of"/>
  <result pre="artery occlusion. Several observational evidences support a potential role of" exact="influenza" post="vaccine in cardiovascular prevention. It is estimated that the"/>
  <result pre="in cardiovascular prevention. It is estimated that the efficacy of" exact="influenza" post="vaccine in preventing myocardial infarction could range between 15%"/>
  <result pre="in the high-risk groups. Influenza vaccine as preventive measure of" exact="cardiovascular disease" post="still awaits support from randomized clinical trials. Nonetheless, considering"/>
  <result pre="trials. Nonetheless, considering the favourable cost-efficacy and safety profile of" exact="influenza" post="vaccination, its use should be encouraged in everyday clinical"/>
  <result pre="has emerged for the flu syndrome. The epidemiological relationship between" exact="acute myocardial infarction" post="(AMI) and flu syndrome was first observed in 1930"/>
  <result pre="mortality due to cardiovascular causes in conjunction with the epidemic" exact="influenza" post="peak.1 To date, during influenza epidemics, there is an"/>
  <result pre="in conjunction with the epidemic influenza peak.1 To date, during" exact="influenza" post="epidemics, there is an increased rate of hospitalization and"/>
  <result pre="review, we will, therefore, examine the possible causal link between" exact="influenza" post="infection and AMI. In general, the search for a"/>
  <result pre="AMI. However, in many of them, the clinical diagnosis of" exact="infectious disease" post="was neither sensitive nor specific for the confirmation of"/>
  <result pre="disease was neither sensitive nor specific for the confirmation of" exact="influenza" post="virus infection. In this regard, Smeeth et al.,3 Who"/>
  <result pre="infarction was 4.95 [95% confidence interval (CI): 4.43–5.53] and the" exact="stroke" post="rate of 3.19 (95% CI: 2.81–3.62). More recently, Warren-Gash"/>
  <result pre="Among other things, it emerged that infections occurring during the" exact="influenza" post="epidemic and those coded as ‘likely to be influenza’"/>
  <result pre="Several studies have, therefore, tried to demonstrate the association between" exact="influenza" post="and SCA through laboratory confirmation of influenza infection; the"/>
  <result pre="the association between influenza and SCA through laboratory confirmation of" exact="influenza" post="infection; the results, however, did not always seem convincing."/>
  <result pre="without AMI. The primary outcome measure was laboratory evidence of" exact="influenza" post="infection. Of 559 participants, 34/275 cases and 19/284 controls"/>
  <result pre="and 19/284 controls were positive for laboratory virus determination for" exact="influenza" post="virus [odds ratio (OR) 1.97; 95% CI: 1.09–3.54]; for"/>
  <result pre="this study demonstrates the existence of a strong association between" exact="influenza" post="infection and AMI, it is limited by the fact"/>
  <result pre="serological tests are less robust than those derived from the" exact="influenza" post="virus laboratory research.7 In this regard, a very recent"/>
  <result pre="of Medicine in January 2018, evaluated the association between laboratory-confirmed" exact="influenza" post="infection with highly specific methods and hospitalization for IMA."/>
  <result pre="higher in the first 7 days after laboratory confirmation of the" exact="influenza" post="infection compared to the control interval, and no increase"/>
  <result pre="ratio was higher for more adult subjects, for Type B" exact="influenza" post="and for patients affected by a first myocardial infarction;"/>
  <result pre="respiratory virus, although minor compared to the secondary forms of" exact="influenza" post="infection. Specifically, an incidence ratio for AMI emerged for"/>
  <result pre="Specifically, an incidence ratio for AMI emerged for Type B" exact="influenza" post="(95% CI: 4.37–23.38), 5.17 for Type A influenza (95%"/>
  <result pre="Type B influenza (95% CI: 4.37–23.38), 5.17 for Type A" exact="influenza" post="(95% CI: 3.02–8.84), 3.51 for respiratory syncytial virus (95%"/>
  <result pre="in this case, it is the septic state, rather than" exact="coronary thrombosis," post="the underlying cause of the flu-related myocardial necrosis. However,"/>
  <result pre="flu-related myocardial necrosis. However, it has been hypothesized that the" exact="influenza" post="through multiple mechanisms can induce or facilitate occlusive phenomena"/>
  <result pre="animal model used for the study of atherosclerosis, infection with" exact="influenza" post="virus induces acute inflammation, proliferation of smooth muscle cells,"/>
  <result pre="It has been hypothesized that the flu infection leads to" exact="acute myocardial infarction" post="through the development of thrombosis on pre-existing atherosclerotic plaques."/>
  <result pre="acute coronary syndrome. Influenza vaccination for secondary prevention of coronary" exact="heart disease" post="‘Indirect’ evidence of a possible association between influenza and"/>
  <result pre="coronary heart disease ‘Indirect’ evidence of a possible association between" exact="influenza" post="and AMI derives from studies showing that influenza vaccination"/>
  <result pre="association between influenza and AMI derives from studies showing that" exact="influenza" post="vaccination is effective in the prevention of ischaemic heart"/>
  <result pre="that influenza vaccination is effective in the prevention of ischaemic" exact="heart disease." post="This, in addition to strengthening the causality between the"/>
  <result pre="of some observational studies show that the protective efficacy of" exact="influenza" post="vaccination from new coronary events in secondary prevention is"/>
  <result pre="published in 2015, Barnes et al.17 estimated the association between" exact="influenza" post="vaccination and occurrence of AMI. A total of eight"/>
  <result pre="or recurrent MI. The results showed a protective efficacy of" exact="influenza" post="vaccination against AMI equal to 29% (95% CI: 9–44%)."/>
  <result pre="randomized clinical trials have evaluated the protection provided by the" exact="influenza" post="vaccine against cardiac events in subjects with pre-existing cardiovascular"/>
  <result pre="the influenza vaccine against cardiac events in subjects with pre-existing" exact="cardiovascular disease," post="the FLU vaccination in ACSs and planned percutaneous coronary"/>
  <result pre="whose goal was to test the potential beneficial effect of" exact="influenza" post="vaccination in secondary prevention. Two hundred patients hospitalized for"/>
  <result pre="subjected to elective coronary angioplasty. Subjects were randomized to receive" exact="influenza" post="or placebo vaccination. In the intention to treat analysis,"/>
  <result pre="which 658 patients were already in optimal medical therapy for" exact="cardiovascular disease" post="were contrasting. In it, 325 subjects received influenza vaccine"/>
  <result pre="for cardiovascular disease were contrasting. In it, 325 subjects received" exact="influenza" post="vaccine and 333 received placebo. The average follow-up was"/>
  <result pre="(major adverse cardiac event, MACE) although not statistically significant. However," exact="influenza" post="vaccination statistically significantly reduced the composite outcome measure of"/>
  <result pre="meta-analysis of these randomized trials, Warren-Gash et al.4,17 showed that" exact="influenza" post="vaccination was protective against IMA, although a statistical analysis"/>
  <result pre="CI: 0.44–1.64). Despite the plausibility of a beneficial effect of" exact="influenza" post="vaccination in the prevention of cardiovascular disease, few studies"/>
  <result pre="a beneficial effect of influenza vaccination in the prevention of" exact="cardiovascular disease," post="few studies have been conducted to explain the possible"/>
  <result pre="interactions, showed a cross-reactivity between the antibody induced by the" exact="influenza" post="vaccination and the human bradykinin receptor (bradykinin B2 receptor,"/>
  <result pre="A principle of coherence is respected: the possibility that the" exact="influenza" post="triggers an ACS agrees with the current scientific data"/>
  <result pre="which acute infections can trigger other vascular events, such as" exact="stroke" post="similar to ACS and, analogously, ACS can be triggered"/>
  <result pre="be greater after lower respiratory tract infections rather than after" exact="urinary tract infection." post="Furthermore, in pneumococcal infections, the more severe the infection"/>
  <result pre="associated with an increased risk of AMI. Why does the" exact="influenza" post="remain a potential focus of particular importance? On the"/>
  <result pre="a potential focus of particular importance? On the one hand," exact="influenza" post="is one of the most frequent respiratory infections, on"/>
  <result pre="we can, therefore, deduce that it is highly probable that" exact="influenza" post="has a causal role in triggering ACS. However, in"/>
  <result pre="event. Although there is evidence to support the role of" exact="influenza" post="vaccination for the prevention of ischaemic heart disease, vaccination"/>
  <result pre="the role of influenza vaccination for the prevention of ischaemic" exact="heart disease," post="vaccination is not considered a priority preventive measure in"/>
  <result pre="encouraged to use vaccination as a preventive measure against ischaemic" exact="heart disease," post="considering its favourable cost-effectiveness and safety profile. In the"/>
  <result pre="there is a change in the paradigm that often sees" exact="influenza" post="vaccination as a simple preventive measure against the infectious"/>
  <result pre="References References 1WuP, GoldsteinE, HoLM, et al.Excess mortality associated with" exact="influenza" post="A and B virus in Hong Kong, 1998-2009. J"/>
  <result pre="Med1965;58:295–300.14283879 3SmeethL, ThomasSL, HallAJ, et al.Risk of myocardial infarction and" exact="stroke" post="after acute infection or vaccination. N Engl J Med2004;351:2611–2618.15602021"/>
  <result pre="Engl J Med2004;351:2611–2618.15602021 4Warren-GashC, SmeethL, HaywardAC.Influenza as a trigger for" exact="acute myocardial infarction" post="or death from cardiovascular disease: a systematic review. Lancet"/>
  <result pre="myocardial infarction. Ann Clin Res1981;13:429–432.6814338 6MacintyreCR, HeywoodAE, KovoorP, et al.Ischaemic" exact="heart disease," post="influenza and influenza vaccination: a prospective case control study."/>
  <result pre="Ann Clin Res1981;13:429–432.6814338 6MacintyreCR, HeywoodAE, KovoorP, et al.Ischaemic heart disease," exact="influenza" post="and influenza vaccination: a prospective case control study. Heart2013;99:1843–1848.23966030"/>
  <result pre="Res1981;13:429–432.6814338 6MacintyreCR, HeywoodAE, KovoorP, et al.Ischaemic heart disease, influenza and" exact="influenza" post="vaccination: a prospective case control study. Heart2013;99:1843–1848.23966030 7GuanX, YangW,"/>
  <result pre="case control study. Heart2013;99:1843–1848.23966030 7GuanX, YangW, SunX, et al.Association of" exact="influenza" post="virus infection and inflammatory cytokines with acute myocardial infarction."/>
  <result pre="et al.Association of influenza virus infection and inflammatory cytokines with" exact="acute myocardial infarction." post="Inflamm Res2012;61:591–598.22373653 8KwongJC, SchwartzKL, CampitelliMA, et al.Acute myocardial infarction"/>
  <result pre="Res2012;61:591–598.22373653 8KwongJC, SchwartzKL, CampitelliMA, et al.Acute myocardial infarction after laboratory-confirmed" exact="influenza" post="infection. N Engl J Med2018;378:345–353.29365305 9Corrales-MedinaVF, MadjidM, MusherDM.Role of"/>
 </snippets>
</snippetsTree>
